
1. OVERVIEW & PROTOCOL
- Compound Structure: TB-500 is a synthetic peptide fragment derived from the active region of Thymosin Beta-4, characterized as a synthesized reagent for in-vitro laboratory evaluation.
- Biological Focus: Investigate cellular migration cascades, protein interaction kinetics, and biochemical profiling within regulated laboratory environments.
- Cellular Intensity: Developed for cell-culture models to monitor targeted biochemical mechanisms, molecular pathways, and structural protein interactions.
2. CHEMICAL PROPERTIES
- Chemical Formula: C212H350N56O78 (Thymosin β4 Active Fragment Sequence: C38H68N10O14)
- Molecular Weight: 4963.4 g/mol (Active Fragment: 889.02 g/mol)
- CAS Number: 88534-08-9
- Amino Acid Count: 7 residues (Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH sequence)
- Reconstitution Protocol: Soluble in bacteriostatic water; reconstitution should be conducted with a lot-specific solvent volume for precise laboratory research recommendations.
- Storage Protocol: Store lyophilized white powder format at -20°C, thoroughly protected from light, moisture, and repeated temperature cycling. Refrigerate reconstituted solutions at 2-8°C.
3. AUDITED RESEARCH & SPECIFICATIONS
- Stability Advantage: Supplied strictly as a characterized, solid-phase peptide synthesis reference material engineered for controlled in-vitro and rodent-model laboratory work only.
- Signaling Pathways: Highly focused on actin-sequestration biochemistry, structural protein dynamics, and cellular migration scratch-wound assays.
- Regulatory Warning: This product is a research chemical supplied strictly for laboratory use only. It is not approved by the FDA and is not intended for human or veterinary consumption.
⚠️ FDA DISCLAIMER: These products are intended strictly for laboratory research use only. They are not intended for human consumption, diagnostic, or therapeutic purposes. The statements on this website have not been evaluated by the Food and Drug Administration.





